Brokerages Set Green Thumb Industries Inc. (OTCMKTS:GTBIF) Target Price at $16.50

Shares of Green Thumb Industries Inc. (OTCMKTS:GTBIF) have received an average recommendation of “Strong Buy” from the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a buy rating and three have given a strong buy rating to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $16.50.

Several brokerages have recently weighed in on GTBIF. Ventum Cap Mkts upgraded Green Thumb Industries to a “strong-buy” rating in a research report on Tuesday, August 6th. Craig Hallum raised Green Thumb Industries to a “strong-buy” rating in a research note on Monday, September 16th. Finally, Roth Capital raised Green Thumb Industries to a “strong-buy” rating in a research note on Sunday, November 10th.

Green Thumb Industries Price Performance

OTCMKTS:GTBIF opened at $9.41 on Tuesday. The company has a market capitalization of $1.99 billion, a P/E ratio of 34.85 and a beta of 1.40. Green Thumb Industries has a 1 year low of $7.50 and a 1 year high of $16.33. The business has a fifty day simple moving average of $10.20 and a two-hundred day simple moving average of $11.00.

Green Thumb Industries (OTCMKTS:GTBIF) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). The company had revenue of $286.87 million during the quarter, compared to analysts’ expectations of $283.96 million. Green Thumb Industries had a net margin of 5.38% and a return on equity of 3.39%. As a group, analysts anticipate that Green Thumb Industries will post 0.32 earnings per share for the current year.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.